Literature DB >> 27001953

High-Resolution Longitudinal Study of HIV-1 Env Vaccine-Elicited B Cell Responses to the Virus Primary Receptor Binding Site Reveals Affinity Maturation and Clonal Persistence.

Yimeng Wang1, Christopher Sundling2, Richard Wilson3, Sijy O'Dell4, Yajing Chen5, Kaifan Dai5, Ganesh E Phad6, Jiang Zhu7, Yongli Xiao8, John R Mascola4, Gunilla B Karlsson Hedestam6, Richard T Wyatt9, Yuxing Li10.   

Abstract

Because of the genetic variability of the HIV-1 envelope glycoproteins (Env), the elicitation of neutralizing Abs to conserved neutralization determinants including the primary receptor binding site, CD4 binding site (CD4bs), is a major focus of vaccine development. To gain insight into the evolution of Env-elicited Ab responses, we used single B cell analysis to interrogate the memory B cell Ig repertoires from two rhesus macaques after five serial immunizations with Env/adjuvant. We observed that the CD4bs-specific repertoire displayed unique features in the third CDR of Ig H chains with minor alterations along the immunization course. Progressive affinity maturation occurred as evidenced by elevated levels of somatic hypermutation (SHM) in Ab sequences isolated at the late immunization time point compared with the early time point. Abs with higher SHM were associated with increased binding affinity and virus neutralization capacity. Moreover, a notable portion of the CD4bs-specific repertoire was maintained between early and late immunization time points, suggesting that persistent clonal lineages were induced by Env vaccination. Furthermore, we found that the predominant persistent CD4bs-specific clonal lineages had larger population sizes and higher affinities than that from the rest of the repertoires, underscoring the critical role of Ag affinity selection in Ab maturation and clonal expansion. Genetic and functional analyses revealed that the accumulation of SHM in both framework regions and CDRs contributed to the clonal affinity and antigenicity evolution. Our longitudinal study provides high-resolution understanding of the dynamically evolving CD4bs-specific B cell response after Env immunization in primates.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27001953      PMCID: PMC4868635          DOI: 10.4049/jimmunol.1502543

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  Limits for antibody affinity maturation and repertoire diversification in hypervaccinated humans.

Authors:  Tine Rugh Poulsen; Allan Jensen; John S Haurum; Peter S Andersen
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

2.  Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing.

Authors:  Xueling Wu; Tongqing Zhou; Jiang Zhu; Baoshan Zhang; Ivelin Georgiev; Charlene Wang; Xuejun Chen; Nancy S Longo; Mark Louder; Krisha McKee; Sijy O'Dell; Stephen Perfetto; Stephen D Schmidt; Wei Shi; Lan Wu; Yongping Yang; Zhi-Yong Yang; Zhongjia Yang; Zhenhai Zhang; Mattia Bonsignori; John A Crump; Saidi H Kapiga; Noel E Sam; Barton F Haynes; Melissa Simek; Dennis R Burton; Wayne C Koff; Nicole A Doria-Rose; Mark Connors; James C Mullikin; Gary J Nabel; Mario Roederer; Lawrence Shapiro; Peter D Kwong; John R Mascola
Journal:  Science       Date:  2011-08-11       Impact factor: 47.728

3.  Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies.

Authors:  Michael S Seaman; Holly Janes; Natalie Hawkins; Lauren E Grandpre; Colleen Devoy; Ayush Giri; Rory T Coffey; Linda Harris; Blake Wood; Marcus G Daniels; Tanmoy Bhattacharya; Alan Lapedes; Victoria R Polonis; Francine E McCutchan; Peter B Gilbert; Steve G Self; Bette T Korber; David C Montefiori; John R Mascola
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

4.  Immune-correlates analysis of an HIV-1 vaccine efficacy trial.

Authors:  Barton F Haynes; Peter B Gilbert; M Juliana McElrath; Susan Zolla-Pazner; Georgia D Tomaras; S Munir Alam; David T Evans; David C Montefiori; Chitraporn Karnasuta; Ruengpueng Sutthent; Hua-Xin Liao; Anthony L DeVico; George K Lewis; Constance Williams; Abraham Pinter; Youyi Fong; Holly Janes; Allan DeCamp; Yunda Huang; Mangala Rao; Erik Billings; Nicos Karasavvas; Merlin L Robb; Viseth Ngauy; Mark S de Souza; Robert Paris; Guido Ferrari; Robert T Bailer; Kelly A Soderberg; Charla Andrews; Phillip W Berman; Nicole Frahm; Stephen C De Rosa; Michael D Alpert; Nicole L Yates; Xiaoying Shen; Richard A Koup; Punnee Pitisuttithum; Jaranit Kaewkungwal; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Nelson L Michael; Jerome H Kim
Journal:  N Engl J Med       Date:  2012-04-05       Impact factor: 91.245

5.  Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.

Authors:  Xueling Wu; Zhi-Yong Yang; Yuxing Li; Carl-Magnus Hogerkorp; William R Schief; Michael S Seaman; Tongqing Zhou; Stephen D Schmidt; Lan Wu; Ling Xu; Nancy S Longo; Krisha McKee; Sijy O'Dell; Mark K Louder; Diane L Wycuff; Yu Feng; Martha Nason; Nicole Doria-Rose; Mark Connors; Peter D Kwong; Mario Roederer; Richard T Wyatt; Gary J Nabel; John R Mascola
Journal:  Science       Date:  2010-07-08       Impact factor: 47.728

6.  Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01.

Authors:  Yuxing Li; Sijy O'Dell; Laura M Walker; Xueling Wu; Javier Guenaga; Yu Feng; Stephen D Schmidt; Krisha McKee; Mark K Louder; Julie E Ledgerwood; Barney S Graham; Barton F Haynes; Dennis R Burton; Richard T Wyatt; John R Mascola
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

7.  HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages.

Authors:  M Anthony Moody; Nicole L Yates; Joshua D Amos; Mark S Drinker; Joshua A Eudailey; Thaddeus C Gurley; Dawn J Marshall; John F Whitesides; Xi Chen; Andrew Foulger; Jae-Sung Yu; Ruijun Zhang; R Ryan Meyerhoff; Robert Parks; Julia Cavanaugh Scull; Lu Wang; Nathan A Vandergrift; Joy Pickeral; Justin Pollara; Garnett Kelsoe; S Munir Alam; Guido Ferrari; David C Montefiori; Gerald Voss; Hua-Xin Liao; Georgia D Tomaras; Barton F Haynes
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

8.  Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.

Authors:  Merlin L Robb; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Punnee Pitisuttithum; Jaranit Kaewkungwal; Prayura Kunasol; Chirasak Khamboonruang; Prasert Thongcharoen; Patricia Morgan; Michael Benenson; Robert M Paris; Joseph Chiu; Elizabeth Adams; Donald Francis; Sanjay Gurunathan; Jim Tartaglia; Peter Gilbert; Don Stablein; Nelson L Michael; Jerome H Kim
Journal:  Lancet Infect Dis       Date:  2012-05-30       Impact factor: 25.071

9.  Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates.

Authors:  Christopher Sundling; Mattias N E Forsell; Sijy O'Dell; Yu Feng; Bimal Chakrabarti; Srinivas S Rao; Karin Loré; John R Mascola; Richard T Wyatt; Iyadh Douagi; Gunilla B Karlsson Hedestam
Journal:  J Exp Med       Date:  2010-08-02       Impact factor: 14.307

10.  Comparison of antibody repertoires produced by HIV-1 infection, other chronic and acute infections, and systemic autoimmune disease.

Authors:  Felix Breden; Christa Lepik; Nancy S Longo; Marinieve Montero; Peter E Lipsky; Jamie K Scott
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

View more
  22 in total

1.  Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability.

Authors:  Xuelian Zhao; Katie A Howell; Shihua He; Jennifer M Brannan; Anna Z Wec; Edgar Davidson; Hannah L Turner; Chi-I Chiang; Lin Lei; J Maximilian Fels; Hong Vu; Sergey Shulenin; Ashley N Turonis; Ana I Kuehne; Guodong Liu; Mi Ta; Yimeng Wang; Christopher Sundling; Yongli Xiao; Jennifer S Spence; Benjamin J Doranz; Frederick W Holtsberg; Andrew B Ward; Kartik Chandran; John M Dye; Xiangguo Qiu; Yuxing Li; M Javad Aman
Journal:  Cell       Date:  2017-05-18       Impact factor: 41.582

Review 2.  Evolution of B cell analysis and Env trimer redesign.

Authors:  Gunilla B Karlsson Hedestam; Javier Guenaga; Martin Corcoran; Richard T Wyatt
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

3.  HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.

Authors:  Yimeng Wang; Sijy O'Dell; Hannah L Turner; Chi-I Chiang; Lin Lei; Javier Guenaga; Richard Wilson; Paola Martinez-Murillo; Nicole Doria-Rose; Andrew B Ward; John R Mascola; Richard T Wyatt; Gunilla B Karlsson Hedestam; Yuxing Li
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

4.  An HIV-1 Env-Antibody Complex Focuses Antibody Responses to Conserved Neutralizing Epitopes.

Authors:  Yajing Chen; Richard Wilson; Sijy O'Dell; Javier Guenaga; Yu Feng; Karen Tran; Chi-I Chiang; Heather E Arendt; Joanne DeStefano; John R Mascola; Richard T Wyatt; Yuxing Li
Journal:  J Immunol       Date:  2016-10-10       Impact factor: 5.422

5.  Polyfunctional Tier 2-Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human Donor.

Authors:  David A Spencer; Delphine C Malherbe; Néstor Vázquez Bernat; Monika Ádori; Benjamin Goldberg; Nicholas Dambrauskas; Heidi Henderson; Shilpi Pandey; Tracy Cheever; Philip Barnette; William F Sutton; Margaret E Ackerman; James J Kobie; D Noah Sather; Gunilla B Karlsson Hedestam; Nancy L Haigwood; Ann J Hessell
Journal:  J Immunol       Date:  2021-01-20       Impact factor: 5.422

Review 6.  Antigenic landscape of the HIV-1 envelope and new immunological concepts defined by HIV-1 broadly neutralizing antibodies.

Authors:  Xueling Wu; Xiang-Peng Kong
Journal:  Curr Opin Immunol       Date:  2016-06-10       Impact factor: 7.486

7.  Prominent Neutralizing Antibody Response Targeting the Ebolavirus Glycoprotein Subunit Interface Elicited by Immunization.

Authors:  Yimeng Wang; Katie A Howell; Jennifer Brannan; Krystle N Agans; Hannah L Turner; Ariel S Wirchnianski; Shweta Kailasan; Marnie Fusco; Andrey Galkin; Chi-I Chiang; Xuelian Zhao; Erica Ollmann Saphire; Kartik Chandran; Andrew B Ward; John M Dye; M Javad Aman; Thomas W Geisbert; Yuxing Li
Journal:  J Virol       Date:  2021-02-03       Impact factor: 6.549

8.  De novo protein design enables the precise induction of RSV-neutralizing antibodies.

Authors:  Fabian Sesterhenn; Che Yang; Jaume Bonet; Johannes T Cramer; Xiaolin Wen; Yimeng Wang; Chi-I Chiang; Luciano A Abriata; Iga Kucharska; Giacomo Castoro; Sabrina S Vollers; Marie Galloux; Elie Dheilly; Stéphane Rosset; Patricia Corthésy; Sandrine Georgeon; Mélanie Villard; Charles-Adrien Richard; Delphyne Descamps; Teresa Delgado; Elisa Oricchio; Marie-Anne Rameix-Welti; Vicente Más; Sean Ervin; Jean-François Eléouët; Sabine Riffault; John T Bates; Jean-Philippe Julien; Yuxing Li; Theodore Jardetzky; Thomas Krey; Bruno E Correia
Journal:  Science       Date:  2020-05-15       Impact factor: 63.714

Review 9.  Lessons learned from human HIV vaccine trials.

Authors:  Justin Pollara; David Easterhoff; Genevieve G Fouda
Journal:  Curr Opin HIV AIDS       Date:  2017-05       Impact factor: 4.283

10.  HIV-1 gp120-CD4-Induced Antibody Complex Elicits CD4 Binding Site-Specific Antibody Response in Mice.

Authors:  Andrey Galkin; Yajing Chen; Javier Guenaga; Sijy O'Dell; Roderico Acevedo; James J Steinhardt; Yimeng Wang; Richard Wilson; Chi-I Chiang; Nicole Doria-Rose; Alexander V Grishaev; John R Mascola; Yuxing Li
Journal:  J Immunol       Date:  2020-02-17       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.